Autophagy and its role in gastric cancer

作者：Cao, Yijing; Luo, Yichen; Zou, Juan; Ouyang, Jun; Cai, Zhihong; Zeng, Xi; Ling, Hui^*; Zeng, Tiebing^*

来源：Clinica Chimica Acta, 2019, 489: 10-20.

DOI：10.1016/j.cca.2018.11.028

• Gastric carcinoma (GC)
• Autophagy
• Signalling pathway
• Prognosis
• Autophagy inhibitor
• Autophagy inducer

Autophagy, which is tightly regulated by a series of autophagy-related genes (ATGs), is a vital intracellular homeostatic process through which defective proteins and organelles are degraded and recycled under starvation, hypoxia or other specific cellular stress conditions. For both normal cells and tumour cells, autophagy not only sustains cell survival but can also promote cell death. Autophagy-related signalling pathways include mTOR-dependent pathways, such as the AMPK/mTOR and PI3K/Akt/mTOR pathways, and non-mTOR dependent pathways, such as the P53 pathway. Additionally, autophagy plays a dual role in gastric carcinoma (GC), including a tumour-suppressor role and a tumour-promoter role. Long-term Heilcobacter pylori infection can impair autophagy, which may eventually promote tumourigenesis of the gastric mucosa. Moreover, Beclin1, LC3 and P62/SQSTM1 are regarded as autophagy-related markers with GC prognostic value. Autophagy inhibitors and autophagy inducers show promise for GC treatment. This review describes research progress regarding autophagy and its significant role in gastric cancer.

• 出版日期2019-2
• 单位湖南大学; 南华大学